Literature DB >> 15976860

The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: fragment couplings, completion of the synthesis, analogue generation and biological evaluation.

Ian Paterson1, David Y-K Chen, Mark J Coster, José L Aceña, Jordi Bach, Debra J Wallace.   

Abstract

The antimitotic marine macrolide altohyrtin A/spongistatin 1 has been synthesised in a highly convergent and stereocontrolled manner, thus contributing to the replenishment of the largely exhausted material from the initial isolation work. Coupling of the AB- and CD-spiroacetal subunits by a stereoselective aldol reaction was achieved by using either a lithium (67 : 33 dr) or boron enolate (90 : 10 dr). A highly (Z)-selective Wittig coupling was used to unite the northern hemisphere aldehyde with the southern hemisphere phosphonium salt . Deprotection and subsequent regioselective macrolactonisation on a triol seco-acid completed the synthesis of altohyrtin A. Two structural analogues were also prepared and evaluated as growth inhibitory agents against a range of human tumour cell lines, including Taxol-resistant strains, alongside altohyrtin A and paclitaxel (Taxol), revealing that dehydration in the E-ring is tolerated and results in enhanced cytotoxicity (at the low picomolar level), whereas the presence of the full C44-C51 side-chain appears to be crucial for biological activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976860     DOI: 10.1039/b504151a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  10 in total

1.  Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1.

Authors:  Amos B Smith; Chris Sfouggatakis; Christina A Risatti; Jeffrey B Sperry; Wenyu Zhu; Victoria A Doughty; Takashi Tomioka; Dimitar B Gotchev; Clay S Bennett; Satoshi Sakamoto; Onur Atasoylu; Shohei Shirakami; David Bauer; Makoto Takeuchi; Jyunichi Koyanagi; Yasuharu Sakamoto
Journal:  Tetrahedron       Date:  2009-09-15       Impact factor: 2.457

2.  Design, synthesis, and biological evaluation of EF- and ABEF- analogues of (+)-spongistatin 1.

Authors:  Amos B Smith; Christina A Risatti; Onur Atasoylu; Clay S Bennett; Karen Tendyke; Qunli Xu
Journal:  Org Lett       Date:  2010-04-16       Impact factor: 6.005

3.  Marine natural products: a new wave of drugs?

Authors:  Rana Montaser; Hendrik Luesch
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

4.  Exploiting pseudo C2-symmetry for an efficient synthesis of the F-ring of the spongistatins.

Authors:  Paul S Tanis; Joshua R Infantine; James L Leighton
Journal:  Org Lett       Date:  2013-10-10       Impact factor: 6.005

5.  Toward a more step-economical and scalable synthesis of spongistatin 1 to facilitate cancer drug development efforts.

Authors:  Samuel K Reznik; James L Leighton
Journal:  Chem Sci       Date:  2013-04-01       Impact factor: 9.825

6.  Complex fragment coupling by crotylation: A powerful tool for polyketide natural product synthesis.

Authors:  Samuel K Reznik; Brian S Marcus; James L Leighton
Journal:  Chem Sci       Date:  2012-11-01       Impact factor: 9.825

Review 7.  A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2010.

Authors:  Marc Schumacher; Mareike Kelkel; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2011-06-30       Impact factor: 4.411

8.  Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1.

Authors:  Linda M Suen; Makeda A Tekle-Smith; Kevin S Williamson; Joshua R Infantine; Samuel K Reznik; Paul S Tanis; Tyler D Casselman; Dan L Sackett; James L Leighton
Journal:  Nat Commun       Date:  2018-11-09       Impact factor: 14.919

Review 9.  Recent synthetic approaches toward non-anomeric spiroketals in natural products.

Authors:  Sylvain Favre; Pierre Vogel; Sandrine Gerber-Lemaire
Journal:  Molecules       Date:  2008       Impact factor: 4.411

Review 10.  A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011.

Authors:  Wamtinga Richard Sawadogo; Marc Schumacher; Marie-Hélène Teiten; Claudia Cerella; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.